METHOD OF PREDICTING RESPONSIVENESS OF LUNG CANCER TREATMENT TO EGFR TARGETING AGENT

摘要

The present invention relates to a method of improving a treatment effect of a patient with acquired tolerance by predicting the responsiveness of a non-small cell lung cancer patient to an agent targeting an epidermal growth factor receptor (EGFR). According to the present invention, the method can predict the responsiveness of the lung cancer patient to a treatment, thereby solving problems of low chances of successful treatment due to tolerance, estimating the prognosis of an anticancer drug, and deciding a therapy plan. [Reference numerals] (AA,CC) Case number; (BB,DD) IHC photo; (CC) Nano C-S-H 0.2%